31st Jul 2023 7:00 am |
RNS |
Permission for first import of Psilocybin |
28th Jul 2023 9:05 am |
RNS |
Resignation of Joint Company Secretary |
28th Jul 2023 8:00 am |
RNS |
June 2023 Quarter Activity Report and Cash Flow |
21st Jul 2023 10:56 am |
RNS |
Holding(s) in Company |
18th Jul 2023 11:41 am |
RNS |
PDMR Notification |
14th Jul 2023 7:00 am |
RNS |
£0.7 million Fundraising |
12th Jul 2023 7:00 am |
RNS |
Further re AMC Places another $1M Order of ArtemiC |
7th Jul 2023 7:00 am |
RNS |
AMC Places Another US$1M Order of ArtemiC™ |
3rd Jul 2023 7:00 am |
RNS |
Reclassification of Psychedelic Compounds |
30th Jun 2023 9:31 am |
RNS |
Details of Company Address |
30th Jun 2023 9:30 am |
RNS |
Company Update |
29th Jun 2023 10:22 am |
RNS |
Results of Shareholder’s General Meeting |
1st Jun 2023 7:30 am |
RNS |
Appointment of Non-Executive Director |
31st May 2023 7:00 am |
RNS |
First CannEpil® delivered to UK patients |
30th May 2023 7:01 am |
RNS |
Corporate Update - Board and UK Adviser Changes |
30th May 2023 7:00 am |
RNS |
Dispatch of General Meeting Documents |
18th May 2023 12:00 pm |
RNS |
Director/PDMR Shareholding |
10th May 2023 5:05 pm |
RNS |
Director/PDMR Shareholding |
2nd May 2023 7:00 am |
RNS |
Malta Production Facility Receives EU-GMP Approval |
28th Apr 2023 7:13 am |
RNS |
March 2023 Quarterly Activities and Cash Flow |
13th Apr 2023 7:00 am |
RNS |
Fundraise closed raising a total of £2,090,890 |
11th Apr 2023 7:01 am |
RNS |
£1.2 million raised in a conditional Placing |
11th Apr 2023 7:00 am |
RNS |
CannEpil® available by Named Patient Request in UK |
3rd Apr 2023 7:00 am |
RNS |
Approval to Develop and Research with Psilocybin |
21st Mar 2023 9:05 am |
RNS |
Second Price Monitoring Extn |
21st Mar 2023 9:00 am |
RNS |
Price Monitoring Extension |
21st Mar 2023 7:00 am |
RNS |
ArtemiC Listed as OTC Drug; AMC Places US$2m order |
15th Mar 2023 4:35 pm |
RNS |
Price Monitoring Extension |
15th Mar 2023 7:00 am |
RNS |
First patient enrolled in MGC ZAM App |
8th Mar 2023 9:00 am |
RNS |
US$500,000 funding received under Mercer Facility |
7th Mar 2023 7:00 am |
RNS |
Completion of CimetrA™ Mechanism of Action study |
1st Mar 2023 7:02 am |
RNS |
Appointment of UK Lead Broker and Change of Co Sec |
28th Feb 2023 9:08 am |
RNS |
Half-year Report |
10th Feb 2023 8:45 am |
RNS |
Updated Investor Presentation |
3rd Feb 2023 7:00 am |
RNS |
Provision of US$600,000 funding and change of CFO |
2nd Feb 2023 7:00 am |
RNS |
Extension of Convertible Securities Agreements |
30th Jan 2023 7:00 am |
RNS |
December 2022 Quarterly Activities and Cash Flow |
23rd Jan 2023 4:40 pm |
RNS |
Second Price Monitoring Extn |
23rd Jan 2023 4:35 pm |
RNS |
Price Monitoring Extension |
16th Jan 2023 7:00 am |
RNS |
Change of Adviser – SW4 Partners |